Kanaly Trust’s Boston Scientific BSX Stock Holding History

Kanaly Trust’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1K	Hold	41	–	–	﹤0.01%	857
2016 Q3	$1K	Hold	41	–	–	﹤0.01%	843
2016 Q2	$1K	Buy	+41	New	+$887	﹤0.01%	833
2015 Q4	–	Sell	-69	Closed	-$1K	–	889
2015 Q3	$1K	Hold	69	–	–	﹤0.01%	825
2015 Q2	$1K	Hold	69	–	–	﹤0.01%	812
2015 Q1	$1K	Buy	+69	New	+$1.09K	﹤0.01%	658

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Kanaly Trust's BSX Position: Q4 2016 in Review

Kanaly Trust held its Boston Scientific (BSX) position steady in Q4 2016 at 41 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #857.

Kanaly Trust first reported a position in BSX in Q1 2015 and has held it in 6 quarters since. 556 funds tracked by Wall St. Rank hold BSX as of Q4 2016.

Kanaly Trust held 41 shares of Boston Scientific worth $1K as of Q4 2016.
Kanaly Trust left its Boston Scientific share count unchanged in Q4 2016.
Boston Scientific made up ﹤0.01% of Kanaly Trust's portfolio in Q4 2016, its #857 holding.
Kanaly Trust first reported a position in Boston Scientific in Q1 2015 and has held it in 6 quarters since.
556 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2016.

Based on Kanaly Trust's 13F filing for Q4 2016, filed 23 Jan 2017.